IF YOU | AND | YOU ARE ELIGIBLE FOR |
| Have had type 1 diabetes for less than 3 months | Are between ages 16 and 45 | Effects of Recombinant Human Glutamic Acid Decarboxylase (rhGAD65) Formulated in Alum (GAD-alum) on the Progression of Type 1 Diabetes in New Onset Subjects |
| Have a first degree relative (mother, father, sister, brother, child) with type 1 diabetes | Are between ages 1 and 45 | Natural History Study of the Development of Type 1 Diabetes (TrialNet) |
| Have a second degree relative (cousin, uncle, aunt, niece, nephew, grandparent, or half-sibling) with type 1 diabetes | Are between ages 1 and 20 | Natural History Study of the Development of
Type 1 Diabetes
(TrialNet) |
| Have had type 1 diabetes for less than 12 weeks | Are between ages 12 and 35 | Thymoglobulin (ATG) to Preserve Beta Cell Function in New Onset Type 1 Diabetes |
| Have had type 1 diabetes for at least 2 weeks, but less than 20 weeks | Are between the ages of 12 and 35 years | A Phase II, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of PROCHYMAL™ (ex vivo cultured adult human mesenchymal stem cells) for the treatment of recently diagnosed type 1 diabetes mellitus (T1DM) |
| Have type 1 diabetes | Are Mexican American or African American | The Genetics Study
(TrialNet) |
| Have had type 1 diabetes for less than 3 months | Are between ages 6 and 45 | CTLA 4 (Abatacept) New Onset Study - No Longer Enrolling |
| Are a pregnant woman in your 3rd trimester | The expected baby has a first degree relative with type 1 diabetes | Nutritional Intervention to Prevent Type 1 Diabetes Pilot Trial (TrialNet) - No Longer Enrolling |
| Have a baby less than 5 months of age | The baby has a first degree relative with type 1 diabetes | Nutritional Intervention to Prevent Type 1 Diabetes Pilot Trial (TrialNet) - No Longer Enrolling |
| Have had Type 1 Diabetes for less than 3 months | Are between ages 8 and 45 | Rituximab-New Onset Study
(TrialNet) - No Longer Enrolling |
| Have had Type 1 Diabetes for less than 3 months | Are between ages 8 and 45 | MMF/DZB - New Onset Study
(TrialNet) - No Longer Enrolling |
